JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Search

PerkinElmer Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

-8.6M

47M

Sales

-21M

699M

P/E

Sector Avg

50.083

37.003

EPS

0.4

Dividend yield

0.28

Profit margin

6.675

Employees

11,000

EBITDA

-14M

181M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+18.71% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.28%

2.25%

Next Dividend date

7 lis 2025

Next Ex Dividend date

16 sty 2026

Market Stats

By TradingEconomics

Market Cap

584M

11B

Previous open

0

Previous close

0

News Sentiment

By Acuity

32%

68%

80 / 373 Ranking in Healthcare

PerkinElmer Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

1 lis 2025, 12:56 UTC

Earnings

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1 lis 2025, 12:56 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 lis 2025, 12:20 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 lis 2025, 12:19 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 lis 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1 lis 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

1 lis 2025, 05:00 UTC

Earnings
Acquisitions, Mergers, Takeovers

Berkshire Hathaway Probably Had a Stellar Quarter. Stock Buybacks Are a Wild Card. -- Barrons.com

1 lis 2025, 00:10 UTC

Earnings

Trouble on The Strip -- Barrons.com

31 paź 2025, 23:09 UTC

Earnings

Review & Preview: October Surprise -- Barrons.com

31 paź 2025, 22:44 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 paź 2025, 21:25 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 paź 2025, 21:20 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 paź 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 paź 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 paź 2025, 21:12 UTC

Acquisitions, Mergers, Takeovers

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 paź 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 paź 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

31 paź 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

31 paź 2025, 20:50 UTC

Market Talk
Earnings

Auto & Transport Roundup: Market Talk

31 paź 2025, 20:46 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 paź 2025, 20:22 UTC

Earnings

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 paź 2025, 20:02 UTC

Earnings

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 paź 2025, 19:55 UTC

Market Talk

Crude Futures Fall for Third Straight Month -- Market Talk

31 paź 2025, 19:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 paź 2025, 19:54 UTC

Acquisitions, Mergers, Takeovers

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 paź 2025, 19:26 UTC

Market Talk

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 paź 2025, 18:30 UTC

Earnings

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 paź 2025, 18:23 UTC

Market Talk

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 paź 2025, 18:09 UTC

Earnings

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 paź 2025, 18:08 UTC

Earnings

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Peer Comparison

Price change

PerkinElmer Inc Forecast

Price Target

By TipRanks

18.71% upside

12 Months Forecast

Average 111.1 USD  18.71%

High 125 USD

Low 100 USD

Based on 11 Wall Street analysts offering 12 month price targets forPerkinElmer Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

8

Buy

3

Hold

0

Sell

Sentiment

By Acuity

80 / 373 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat